Expert Chaslau Koniukh
  • Companies
  • Global investment
  • Investors
  • Terminology
  • Economy
  • Stock Market
  • World exchanges
  • Tech and Marketing
Investments in biotechnology
Analytics

Investment in biotechnology reaches record highs: analysis of the Far Eastern High Technology Fund segment

29.05.2021
2 min read

Why investments in biotechnology are becoming more and more popular

Investments in biotechnology are becoming increasingly popular. This segment has been strengthening its position on the stock market for some time, but the pandemic has accelerated this process. Now there is a real excitement among biotech companies – they make IPOs, a lot of venture capital funds are created. According to an analyst from the Far Eastern High Technology Fund, now is the right time to invest in the segment.
Biotechnology has squeezed IT out of the market, becoming the sphere with the highest yield. The priorities of mankind are gradually shifting towards providing comfortable conditions for life and maintaining health.
Last year was very successful for the biotech segment. In just the first 6 months there were initial public offerings of $9.4 billion in the U.S., which was a record. This figure is higher than the results of 2019, when the sector received about $6.5 billion for the entire period. The NASDAQ Biotechnology Index was up 13.25%, while the S&P 500 was up just 6.57%.
Such investor interest did not go unnoticed for the venture capital segment. According to Silicon Valley Bank, in the first half of 2020 the total capital of new venture capital funds amounted to 10.5 billion dollars, and their appearance has not stopped even the pandemic. Approximately the same number of funds were organized for the whole of 2019.

Investments in biotechnology

Even before the pandemic, prominent businessmen were interested in the biotechnology industry. For example, Bill Gates and Jeff Bezos invested in Grail, a company that develops tests that detect the presence of cancer in its early stages. In addition, the founder of Microsoft is a venture investor in the development of synthetic biology, the drugs to treat cancer. Billionaire Warren Buffett recently invested $192 million in the segment, he bought a stake in Biogen, which is engaged in research on Alzheimer’s disease.
According to statistics from Family Capital, about 20 percent of family office investments go to the biotechnology industry. Since 2019, the segment has seen an influx of new types of investors, such as private equity funds. Major players such as KKR and Blackstone have acquired a number of biotech developers.
Even Google and Samsung are investing in the industry, building drug plants and research centers.
The key factor that makes biotech interesting to investors is its capabilities. The introduction of artificial intelligence technologies and the availability of big data processing allows for much faster results, faster research and efficient products. One of the most attractive areas is genomic technology, where the value of projects exceeds $3 billion.

Tags: Analytics
0
Previous Post ASM Pacific Technology Ltd wants to leave the stock exchange in Hong Kong Next Post More and more company owners prefer to withdraw their shares from stock exchanges

You Might Also Like

Expert Chaslau Koniukh
Analytics
Chaslau Koniukh on the analysts’ opinion on the key stake size change soon
18.06.2020
European currency
Analytics
Experts: European currency is not interesting for Russians
15.03.2021
Expert Chaslau Koniukh
Analytics
Analyst Chaslau Koniukh: Chinese digital yuan threatens dollar
18.07.2020
collapse of quotations
Analytics
Is the oil market waiting for another collapse of quotations: the opinion of a LUKOIL analyst?
08.06.2020
Digital Gold
Analytics
Bitcoin: how digital gold develops
01.05.2020
US stock market
Analytics
Oksana Kholodenko, BCS World of Investments: the US stock market is at record highs
15.11.2021

Popular Posts

  • Spain’s economy performs best in the EU
  • Li Ka Shing: How can success be achieved without money and education?
  • Skolkovo analysts: the Russian energy market is suffering losses
  • Ingeborg Mootz: a woman who became a stock player at the age of 75

Editor's Picks

Chaslau Koniukh
Analytics

American bankers from JPMorgan and Goldman Sachs advise to invest in gold: review by Chaslau Koniukh.

Spokesperson
17.08.2020
Expert Chaslau Koniukh
Analytics

Chaslau Koniukh on the analysts’ opinion on the key stake size change soon

Spokesperson
18.06.2020
expert Chaslau Koniukh
Analytics

Chaslau Koniukh: Internet trade market in Russia may reach 2.78 trillion rubles.

Spokesperson
30.05.2020
Will the U.S. oil shale industry be able to quickly recover from the crisis: A Review by Chaslau Koniukh
Analytics

Will the U.S. oil shale industry be able to quickly recover from the crisis: A Review by Chaslau Koniukh

Spokesperson
16.05.2020

Popular Posts

  • Spain’s economy performs best in the EU
  • Li Ka Shing: How can success be achieved without money and education?
  • Skolkovo analysts: the Russian energy market is suffering losses
  • Ingeborg Mootz: a woman who became a stock player at the age of 75
  • Analysts: Egypt’s economy to continue falling in 2023
Expert Chaslau Koniukh
  • Facebook
  • Twitter
  • Instagram

© 2024 CHASLAU KONIUKH. ALL RIGHTS RESERVED. Expert in marketing and project management, international investments, financial analyst.

Menu

  • Biography
  • Companies and corporations
  • Global investment
  • Investors and Entrepreneurs
  • Economy
  • Market terminology
  • Stock Market
  • World exchanges
  • Tech and Marketing
  • Analytics